Cancer in Crohn's disease
https://doi.org/10.33878/2073-7556-2025-24-3-73-78
Abstract
AIM: to assess risk factors for bowel cancer associated with Crohn's disease, as well as to assess the clinical features of the combined pathologies.
PATIENTS AND METHODS: retrospective study included 1,478 medical records of patients with Crohn's disease in 2020–2024. Eleven patients with bowel cancer were identified.
RESULTS: history analysis revealed that colorectal cancer developed mainly in patients with a long history of the CD, in whom inflammatory changes in the intestine were detected at a young age, and complications of the disease were noted as well (fistulas, strictures, perianal manifestations). For CD, patients received therapy with various genetically engineered biological agents. When colorectal cancer was detected, the tumor was localized in the colon or rectum, and had the histological structure of adenocarcinoma. After treatment (neoadjuvant chemoradiation therapy, adjuvant chemotherapy, surgery), patients were followed up for 0–16 months, during this period, relapses of Crohn's disease and colorectal cancer were not detected.
CONCLUSION: further studies are needed to assess the risk factors for the development of bowel cancer in the presence of Crohn's disease, the characteristics of the course of Crohn's disease after diagnosed bowel cancer, and the development of approaches to the diagnosis, treatment, and prevention of such conditions.
About the Authors
S. S. Belous
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation
Russian Federation
Sofia S. Belous.
Salyama Adilya st., 2, Moscow, 123423
B. A. Vykova
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation
Russian Federation
Bella A. Vykova.
Salyama Adilya st., 2, Moscow, 123423
A. A. Ponomarenko
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation
Russian Federation
Alexei A. Ponomarenko.
Salyama Adilya st., 2, Moscow, 123423
M. A. Ignatenko
Ryzhikh National Medical Research Center of Coloproctology
Russian Federation
Russian Federation
Maria A. Ignatenko.
Salyama Adilya st., 2, Moscow, 123423
References
1. Shah SC, Itzkowitz SH. Colorectal Cancer in Inflammatory Bowel Disease. Mechanisms and Management. Gastroenterology. 2022 Mar;162(3):715–730.e3. doi: 10.1053/j.gastro.2021.10.035 Epub 2021 Oct 29. PMID: 34757143; PMCID: PMC9003896.
2. Chin YH, Jain SR, Lee MH, et al. Small bowel adenocarcinoma in Crohn's disease: a systematic review and meta-analysis of the prevalence, manifestation, histopathology, and outcomes. Int J Colorectal Dis. 2022;37:239250. doi: 10.1007/s00384-021-04050-1
3. Canavan C, Abrams KR, Mayberry J. Meta-analysis: colorectal and small bowel cancer risk in patients with Crohn's disease. Aliment Pharmacol Ther. 2006;23:1097–104. doi: 10.1111/j.1365-2036.2006.02854.x
4. Palascak-Juif V, Bouvier AM, Cosnes J, et al. Small bowel adenocarcinoma in patients with Crohn's disease compared with small bowel adenocarcinoma de novo. Inflamm Bowel Dis. 2005;11:828–32. doi: 10.1097/01.mib.0000179211.03650.b6
5. Sasaki H, Ikeuchi H, Bando T, et al. Clinicopathological characteristics of cancer associated with Crohn's disease. Surg Today. 2017 Jan;47(1):35–41. doi: 10.1007/s00595-016-1336-2 Epub 2016 Apr 19. PMID: 27094049; PMCID: PMC5133282.
6. Suttichaimongkol T, Hwang SW, Coelho-Prabhu N, et al. Characteristics, clinical outcomes, and prognostic factors of colorectal cancer in patients with Crohn's disease: American versus Korean tertiary referral center perspectives. Therap Adv Gastroenterol. 2024 Sep 18;17:17562848241275342. doi: 10.1177/17562848241275342 PMID: 39314760; PMCID: PMC11418326.
7. Beaugerie L, Carrat F, Nahon S, et al. High risk of anal and rectal cancer in patients with anal and/or perianal Crohn's disease. Clin Gastroenterol Hepatol. 2018;16:892–899.e2. doi: 10.1016/j.cgh.2017.11.041
8. Wewer MD, Zhao M, Nordholm-Carstensen A, et al. The incidence and disease course of perianal Crohn's disease: a Danish nationwide cohort study, 1997–2015. J CrohnsColitis. 2021;15:5–13. doi: 10.1093/ecco-jcc/jjaa118
9. Winkler R, Wittmer A, Heusermann U. Das karzinombeim m. Crohn. Zeitschrift für Gastroenterologie. 2002;40:569–576. doi: 10.1055/s-2002-33417
10. Wong SY, Rowan C, Brockmans ED, et al. Perianal Fistulizing Crohn's Disease-Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus. Clin Gastroenterol Hepatol. 2024 Jun 12:S1542–3565(24)00504-4. doi: 10.1016/j.cgh.2024.05.029 Epub ahead of print. PMID: 38871152.
11. Palmieri C, Muller G, Kroesen AJ, et al. Perianal fistula-associated carcinoma in Crohn's disease: a multicentre retrospective case control study. J Crohns Colitis. 2021;15:1686–1693.
Review
For citations:
Belous S.S., Vykova B.A., Ponomarenko A.A., Ignatenko M.A. Cancer in Crohn's disease. Koloproktologia. 2025;24(3):73-78. (In Russ.) https://doi.org/10.33878/2073-7556-2025-24-3-73-78
Views:
13
Email this article 
